Professor, Medicine, Baylor College of Medicine
Endocrinology
Dr. James L. Pool, MD
|
|
Give Review
James Pool practices Endocrinology. He attended University of Oklahoma College of Medicine. He received awards:"Super Doctor". James Pool has written publications. He has 66 publications published with PubMed. The lastest publication is: 'Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker.' James Pool accepts all Medicare patients.
Publications
- The Effect of Angiotensin Receptor Blockade on Insulin Sensitivity and Endothelial Function in Abdominally Obese Hypertensive Patients with Impaired Fasting Glucose.
- Clinical Role of Direct Renin Inhibition in Hypertension.
- AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.
- The Editor's Roundtable: Endothelial dysfunction in cardiovascular Disease.
- Direct renin inhibition: focus on aliskiren.
- Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-...
- The editor's roundtable: concurrent hypertension and dysLipidemia.
- Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
- Clinical pharmacology of antihypertensive therapy.
- Is it time to move to multidrug combinations?
- Current Concepts of Pharmacotherapy in Hypertension - Alpha-Adrenergic Blocking Drugs: Evolving Role in Clinical Medicine.
- The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive ad...
- Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker.
- Dose-response efficacy of valsartan, a new angiotensin II receptor blocker.
- Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.
- Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.
- Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours.
- Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
- Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
- A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
- Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
- Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerabil...
- A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Inves...
- Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
- Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II.
- Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone.
- Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients.
- Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hype...
- Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hyper...
- Spectrum of dysautonomia in mitral valvular prolapse.
- Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
- Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
- Neurosurgical management of carotid sinus hypersensitivity. Report of three cases.
- Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
- Alpha 1-adrenoreceptor blockade and the molecular basis of Lipid metabolism alterations.
- Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patien...
- Plasma norepinephrine concentrations: no differences among normal volunteers and low, high or normal renin hypertensive patients.
- Plasma Lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
- Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
- Lovastatin and coadministered antihypertensive/cardiovascular agents.
- A 3-dimensional analysis of modes of cardiovascular adaptation: concepts, methods and preliminary findings.
- Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.
- Nicardipine as antihypertensive monotherapy: positive effects on quality of life.
- Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.
- Renin-aldosterone profiling in hypertension.
- Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography.
- Pharmacology of angiotensin converting enzyme inhibitors. A review.
- Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure.
- Effect of doxazosin monotherapy on blood pressure and plasma Lipids in patients with essential hypertension.
- Does reducing physician uncertainty improve hypertension control?: rationale and methods.
- Localization of ectopic pheochromocytomas by magnetic resonance imaging.
- Effects of doxazosin on coronary heart Disease risk factors in the hypertensive patient.
- Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia.
- Effects of doxazosin on serum Lipids: a review of the clinical data and molecular basis for altered Lipid metabolism.
- Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
- A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
- The impact of renal fusion and ectopia on aortic surgery.
- Doxazosin: a new approach to hypertension and benign prostatic hyperplasia.
- The role of angiotensin II in hypertension and end-organ damage.
- Isolated renal artery dissection secondary to medial degeneration.
- Cyclic therapy of Osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate.
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up.
- Characteristics of conditioned and sedentary men with acute coronary syndromes.
- Randomised controlled trial of two methods of weaning from high frequency positive pressure ventilation.
- Risk ratio and rate ratio estimation in case-cohort designs: hypertension and cardiovascular mortality.
Schools
University of Oklahoma Health Sciences Center
Duke University Med Center
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Gynecomastia
- Hashimoto's Disease
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Super Doctor
Education
-
Duke University Hospital -
University of Oklahoma College of Medicine
Hospital
-
Michael E. DeBakey Veterans Affairs Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Philip R. Orlander, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheldon Rubenfeld, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yomna T. Monla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian R. Tulloch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Verena M. Hug, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Perry E. Bickel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith A. Aldinger, MD
This Doctor is OpenDoctor Recommended.
|